Contrasting acute effects of vasodilators (nitroglycerin, nitroprusside, and hydralazine) on right ventricular performance in patients with chronic obstructive pulmonary disease and pulmonary hypertension: A combined radionuclide-hemodynamic study-Reference-Cited by-同舟云学术

Contrasting acute effects of vasodilators (nitroglycerin, nitroprusside, and hydralazine) on right ventricular performance in patients with chronic obstructive pulmonary disease and pulmonary hypertension: A combined radionuclide-hemodynamic study

Published:1983-06 Issue:10 Volume:51 Page:1682-1689
ISSN:0002-9149
Container-title:The American Journal of Cardiology
language:en
Short-container-title:The American Journal of Cardiology

Author:

Brent Bruce N.,Berger Harvey J.,Matthay Richard A.,Mahler Donald,Pytlik Linda,Zaret Barry L.

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference29 articles.

1. The role of vasodilator therapy in heart failure;Chatterjee;Prog Cardiovasc Dis,1977

2. Effectiveness of long-term vasodilator administration in the treatment of chronic left ventricular failure;Franciosa;Prog Cardiovasc Dis,1982

3. Tolazoline hydrochloride (Priscoline): an effective pulmonary vasodilator;Grover;Am Heart J,1961

4. Isoproterenol as a potential pulmonary vasodilator in primary pulmonary hypertension;Davoud;Am J Cardiol,1978

5. Primary pulmonary hypertension treated with oral phentolamine;Ruskin;Ann Intern Med,1979

Cited by 69 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Is there a role for nuclear cardiology in pulmonary hypertension?;Journal of Nuclear Cardiology;2024-01

2. The Coexistence of Chronic Obstructive Pulmonary Disease and Heart Failure;Cureus;2021-08-23

3. Pulmonary hemodynamics and wave reflections in adults with atrial septal defects;American Journal of Physiology-Heart and Circulatory Physiology;2020-04-01

4. Cardiac Physiology and Pharmacology;A Practice of Anesthesia for Infants and Children;2019

5. Current challenges in managing comorbid heart failure and COPD;Expert Review of Cardiovascular Therapy;2018-09-02